Treace Medical Concepts (TMCI) Cash from Investing Activities (2020 - 2026)

Treace Medical Concepts has reported Cash from Investing Activities for 7 years, with the latest figure at -$7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 312.67% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 75.34% YoY), and the FY2025 full-year result was $13.3 million, down 62.54% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$7.8 million, down from $9.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $22.4 million in Q2 2024, with the low at -$80.5 million in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$6.9 million across 5 years, with a median of -$1.5 million in 2022.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 7012.44% — and 2024, when it jumped 315.23%.
• Treace Medical Concepts' Cash from Investing Activities stood at -$64.0 million in 2022, then jumped by 107.82% to $5.0 million in 2023, then sank by 31.68% to $3.4 million in 2024, then soared by 182.55% to $9.7 million in 2025, then tumbled by 180.86% to -$7.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$7.8 million (Q1 2026), $9.7 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.